The NBA is extending its policy of not randomly drug testing players for marijuana through the 2021-2022 season, a league spokesperson confirmed on Wednesday.
NBA Commissioner Adam Silver signaled late last year that the temporary suspension of cannabis drug testing may continue. And now Chief Communications Officer Mike Bass is confirming that the policy will be in place at least through the upcoming season that begins this month, according to The Associated Press.
“We have agreed with the [NBA Players Association] to extend the suspension of random testing for marijuana for the 2021-22 season and focus our random testing program on performance-enhancing products and drugs of abuse,” he said.
The development was first reported by ESPN, which obtained a memo on the issue that was recently circulated to NBA players.
Silver said in December that the league’s decision on marijuana drug testing, which was made amid the peak of the coronavirus pandemic, could eventually become permanent.
“We decided that, given all the things that were happening in society, given all the pressures and stress that players were under, that we didn’t need to act as Big Brother right now,” he said at the time. “I think society’s views around marijuana has changed to a certain extent.”
Published: October 07, 2021
Founder & Interim Editor of L.A. Cannabis News